vs

Side-by-side financial comparison of GAIA, INC (GAIA) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

GAIA, INC is the larger business by last-quarter revenue ($25.5M vs $19.6M, roughly 1.3× STANDARD BIOTOOLS INC.). GAIA, INC runs the higher net margin — -0.3% vs -177.4%, a 177.1% gap on every dollar of revenue. On growth, GAIA, INC posted the faster year-over-year revenue change (5.8% vs -11.5%). GAIA, INC produced more free cash flow last quarter ($76.0K vs $-23.1M). Over the past eight quarters, GAIA, INC's revenue compounded faster (9.4% CAGR vs -12.2%).

Gaia, Inc. is a publicly traded (NASDAQ:GAIA) American media company founded in 1988 by Jirka Rysavy in Louisville, Colorado. It owns and operates Gaia TV, a subscription video on-demand service consisting of original and licensed alternative media documentaries, including those on wellness, spirituality and conspiracy theories.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

GAIA vs LAB — Head-to-Head

Bigger by revenue
GAIA
GAIA
1.3× larger
GAIA
$25.5M
$19.6M
LAB
Growing faster (revenue YoY)
GAIA
GAIA
+17.3% gap
GAIA
5.8%
-11.5%
LAB
Higher net margin
GAIA
GAIA
177.1% more per $
GAIA
-0.3%
-177.4%
LAB
More free cash flow
GAIA
GAIA
$23.2M more FCF
GAIA
$76.0K
$-23.1M
LAB
Faster 2-yr revenue CAGR
GAIA
GAIA
Annualised
GAIA
9.4%
-12.2%
LAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
GAIA
GAIA
LAB
LAB
Revenue
$25.5M
$19.6M
Net Profit
$-75.0K
$-34.7M
Gross Margin
87.6%
48.5%
Operating Margin
-2.6%
-168.5%
Net Margin
-0.3%
-177.4%
Revenue YoY
5.8%
-11.5%
Net Profit YoY
91.7%
-28.8%
EPS (diluted)
$-0.02
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GAIA
GAIA
LAB
LAB
Q4 25
$25.5M
Q3 25
$25.0M
$19.6M
Q2 25
$24.6M
$21.8M
Q1 25
$23.8M
$40.8M
Q4 24
$24.1M
Q3 24
$22.0M
$22.1M
Q2 24
$21.9M
$22.5M
Q1 24
$21.3M
$45.5M
Net Profit
GAIA
GAIA
LAB
LAB
Q4 25
$-75.0K
Q3 25
$-1.2M
$-34.7M
Q2 25
$-2.0M
$-33.5M
Q1 25
$-1.2M
$-26.0M
Q4 24
$-907.0K
Q3 24
$-1.2M
$-26.9M
Q2 24
$-2.2M
$-45.7M
Q1 24
$-971.0K
$-32.2M
Gross Margin
GAIA
GAIA
LAB
LAB
Q4 25
87.6%
Q3 25
86.4%
48.5%
Q2 25
86.7%
48.8%
Q1 25
87.7%
48.4%
Q4 24
88.2%
Q3 24
86.1%
54.9%
Q2 24
84.5%
46.1%
Q1 24
85.3%
53.1%
Operating Margin
GAIA
GAIA
LAB
LAB
Q4 25
-2.6%
Q3 25
-5.0%
-168.5%
Q2 25
-8.9%
-118.1%
Q1 25
-4.3%
-80.8%
Q4 24
-7.1%
Q3 24
-5.3%
-120.9%
Q2 24
-9.1%
-134.5%
Q1 24
-4.0%
-132.2%
Net Margin
GAIA
GAIA
LAB
LAB
Q4 25
-0.3%
Q3 25
-4.6%
-177.4%
Q2 25
-8.3%
-153.7%
Q1 25
-5.1%
-63.8%
Q4 24
-3.8%
Q3 24
-5.4%
-122.0%
Q2 24
-9.9%
-203.3%
Q1 24
-4.6%
-70.6%
EPS (diluted)
GAIA
GAIA
LAB
LAB
Q4 25
$-0.02
Q3 25
$-0.05
$-0.09
Q2 25
$-0.07
$-0.09
Q1 25
$-0.04
$-0.07
Q4 24
$-0.03
Q3 24
$-0.05
$-0.07
Q2 24
$-0.09
$-0.12
Q1 24
$-0.05
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GAIA
GAIA
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$13.5M
$129.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.9M
$399.7M
Total Assets
$154.6M
$539.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GAIA
GAIA
LAB
LAB
Q4 25
$13.5M
Q3 25
$14.2M
$129.4M
Q2 25
$13.9M
$158.6M
Q1 25
$13.1M
$150.9M
Q4 24
$5.9M
Q3 24
$4.4M
$210.6M
Q2 24
$5.5M
$269.8M
Q1 24
$8.6M
$287.1M
Total Debt
GAIA
GAIA
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Stockholders' Equity
GAIA
GAIA
LAB
LAB
Q4 25
$87.9M
Q3 25
$86.3M
$399.7M
Q2 25
$85.7M
$424.5M
Q1 25
$87.0M
$454.6M
Q4 24
$80.7M
Q3 24
$81.2M
$489.3M
Q2 24
$82.1M
$510.3M
Q1 24
$84.8M
$577.3M
Total Assets
GAIA
GAIA
LAB
LAB
Q4 25
$154.6M
Q3 25
$151.1M
$539.6M
Q2 25
$147.0M
$557.0M
Q1 25
$148.5M
$579.6M
Q4 24
$141.2M
Q3 24
$139.6M
$681.5M
Q2 24
$142.1M
$708.7M
Q1 24
$133.8M
$777.7M
Debt / Equity
GAIA
GAIA
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GAIA
GAIA
LAB
LAB
Operating Cash FlowLast quarter
$1.8M
$-22.2M
Free Cash FlowOCF − Capex
$76.0K
$-23.1M
FCF MarginFCF / Revenue
0.3%
-118.1%
Capex IntensityCapex / Revenue
6.6%
4.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-377.0K
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GAIA
GAIA
LAB
LAB
Q4 25
$1.8M
Q3 25
$326.0K
$-22.2M
Q2 25
$2.3M
$-20.7M
Q1 25
$1.3M
$-30.3M
Q4 24
$2.7M
Q3 24
$409.0K
$-27.9M
Q2 24
$-2.1M
$-39.0M
Q1 24
$5.9M
$-62.5M
Free Cash Flow
GAIA
GAIA
LAB
LAB
Q4 25
$76.0K
Q3 25
$-1.6M
$-23.1M
Q2 25
$880.0K
$-22.6M
Q1 25
$268.0K
$-35.3M
Q4 24
$1.6M
Q3 24
$-952.0K
$-30.1M
Q2 24
$-3.5M
$-41.0M
Q1 24
$4.9M
$-63.3M
FCF Margin
GAIA
GAIA
LAB
LAB
Q4 25
0.3%
Q3 25
-6.4%
-118.1%
Q2 25
3.6%
-103.6%
Q1 25
1.1%
-86.6%
Q4 24
6.5%
Q3 24
-4.3%
-136.4%
Q2 24
-16.1%
-182.2%
Q1 24
22.8%
-138.9%
Capex Intensity
GAIA
GAIA
LAB
LAB
Q4 25
6.6%
Q3 25
7.7%
4.5%
Q2 25
5.7%
8.7%
Q1 25
4.3%
12.4%
Q4 24
4.6%
Q3 24
6.2%
10.2%
Q2 24
6.6%
8.6%
Q1 24
5.0%
1.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GAIA
GAIA

US$16.7M65%
Non Us$8.8M35%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons